Start for free
Start for free
SMS Group logo

SMS Group

Europe, Nordrhein-Westfalen, Germany, Düsseldorf

Description

SMS Group offers quality plants, machinery and services to the metallurgical firms for steel, aluminum, copper and metals.

Investor Profile

SMS Group has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Series C (25%)
  • Series B (25%)

Country Focus

  • Germany (75%)
  • Sweden (25%)

Industry Focus

  • Health Care
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SMS Group frequently co-invest with?

RV
Remiges Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
KfW
KfW
Europe, Hessen, Germany, Frankfurt
Co-Investments: 3
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 2
Forbion Capital Partners
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 1
TF
Co-Investments: 2
Altor
Altor
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
VF
VC Fonds Technologie Berlin
Europe, Berlin, Germany, Berlin
Co-Investments: 3
Vesalius Biocapital Partners
Vesalius Biocapital Partners
Europe, Luxembourg, Luxembourg, Strassen
Co-Investments: 3
S
Co-Investments: 1
KG Investments
KG Investments
North America, Arizona, United States, Scottsdale
Co-Investments: 1

Which angels does SMS Group often collaborate with?

CS
Cristina Stenbeck
Europe, Stockholms Lan, Sweden, Stockholm
Shared Deals: 1
Daniel Ek
Daniel Ek
North America, New York, United States, New York
Shared Deals: 1
AM
Ane Mærsk Mc-Kinney Uggla
Europe, Stockholms Lan, Sweden, Stockholm
Shared Deals: 1

What are some of recent deals done by SMS Group?

H2 Green Steel

Stockholm, Stockholms Lan, Sweden

H2 Green Steel operates a steel production plant to accelerate the decarbonization of the steel industry using green energy.

Series AMay 24, 2021
Amount Raised: $105,000,000
OMEICOS Therapeutics

Berlin, Berlin, Germany

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Health CareMedicalTherapeutics
Series CNov 2, 2018
Amount Raised: $19,357,777
OMEICOS Therapeutics

Berlin, Berlin, Germany

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Health CareMedicalTherapeutics
Series BMar 1, 2017
Amount Raised: $8,744,832
OMEICOS Therapeutics

Berlin, Berlin, Germany

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.

Health CareMedicalTherapeutics
Series AApr 15, 2015
Amount Raised: $6,619,264
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator